"Carcinoma, Lobular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
Descriptor ID |
D018275
|
MeSH Number(s) |
C04.557.470.200.025.305 C04.557.470.615.305 C04.588.180.437 C17.800.090.500.437
|
Concept/Terms |
Carcinoma, Lobular- Carcinoma, Lobular
- Carcinomas, Lobular
- Lobular Carcinoma
- Lobular Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Lobular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Lobular".
This graph shows the total number of publications written about "Carcinoma, Lobular" by people in this website by year, and whether "Carcinoma, Lobular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2006 | 0 | 1 | 1 |
2007 | 0 | 2 | 2 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Lobular" by people in Profiles.
-
Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract. Int J Gynecol Pathol. 2023 Jul 01; 42(4):414-420.
-
Correlation of p16 Expression on Cancer and Stromal Cells With Clinicopathologic and Immunohistochemical Features of Lobular Breast Carcinoma. Appl Immunohistochem Mol Morphol. 2019 10; 27(9):658-662.
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx? for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
-
Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer. Acta Cytol. 2017; 61(2):140-144.
-
Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma. Appl Immunohistochem Mol Morphol. 2016 Nov/Dec; 24(10):738-743.
-
Breast Imaging Second Opinions Impact Surgical Management. Ann Surg Oncol. 2015 Jul; 22(7):2359-64.
-
Correlation of clinicopathologic parameters and immunohistochemical features of triple-negative invasive lobular carcinoma. Appl Immunohistochem Mol Morphol. 2014 Jul; 22(6):e18-26.
-
Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):25-31.
-
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Res Treat. 2007 Dec; 106(2):181-9.
-
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol. 2006 Feb; 19(2):307-19.